Toremifenum

Toremifenum Uses, Dosage, Side Effects, Food Interaction and all others data.

A first generation nonsteroidal selective estrogen receptor modulator (SERM) that is structurally related to tamoxifen. Like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.

Toremifenum is an antineoplastic hormonal agent primarily used in the treatment of advanced breast cancer. Toremifenum is a nonsteroidal agent that has demonstrated potent antiestrogenic properties in animal test systems. The antiestrogenic effects may be related to its ability to compete with estrogen for binding sites in target tissues such as breast. Toremifenum inhibits the induction of rat mammary carcinoma induced by dimethylbenzanthracene (DMBA) and causes the regression of already established DMBA-induced tumors. In this rat model, Toremifenum appears to exert its antitumor effects by binding the estrogen receptors. In cytosols derived from human breast adenocarcinomas, Toremifenum competes with estradiol for estrogen receptor protein.

Trade Name Toremifenum
Availability Prescription only
Generic Toremifene
Toremifene Other Names Toremifene, Toremifeno, Toremifenum
Related Drugs Arimidex, Ibrance, Femara, Xeloda, Herceptin, Lynparza
Type
Formula C26H28ClNO
Weight Average: 405.96
Monoisotopic: 405.18594223
Protein binding

Toremifen is primarily bound to albumin (92%), 2% bound to α1-acid glycoprotein, and 6% bound to β1-globulin in the serum.

Groups Approved, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Toremifenum
Toremifenum

Uses

Toremifenum is a first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers.

For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifenum is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer.

Toremifenum is also used to associated treatment for these conditions: Desmoid Tumors, Metastatic Breast Cancer

How Toremifenum works

Toremifenum is a nonsteroidal triphenylethylene derivative. Toremifenum binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activities, depending upon the duration of treatment, animal species, gender, target organ, or endpoint selected. The antitumor effect of toremifene in breast cancer is believed to be mainly due to its antiestrogenic effects, in other words, its ability to compete with estrogen for binding sites in the cancer, blocking the growth-stimulating effects of estrogen in the tumor. Toremifenum may also inhibit tumor growth through other mechanisms, such as induction of apoptosis, regulation of oncogene expression, and growth factors.

Food Interaction

  • Avoid grapefruit products. Grapefruit inhibits CYP3A4 and therefore, may elevate toremifene serum levels.
  • Take with or without food.

[Moderate] GENERALLY AVOID: Coadministration with grapefruit juice may theoretically increase the plasma concentrations of toremifene.

The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruit.

Because toremifene is associated with dose- and concentration-dependent prolongation of the QT interval, increased levels may potentiate the risk of ventricular arrhythmias such as torsade de pointes and sudden death.

GENERALLY AVOID: Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of toremifene.

Supportive data are derived primarily from in vitro and animal studies.

In vitro, low concentrations of these phytoestrogens have been found to promote DNA synthesis and reverse the inhibitory effect of tamoxifen on oestrogen-dependent breast cancer cell proliferation.

In contrast, high concentrations of genistein greater than 10 microM

It is not known if these high concentrations are normally achieved in humans.

Plasma concentrations below 4 microM

These concentrations are comparable to the low plasma concentrations associated with tumor stimulation reported in animals.

In a study of 155 female breast cancer survivors with substantially bothersome hot flashes, a product containing 50 mg of soy isoflavones (40% to 45% genistein; 40% to 45% daidzein; 10% to 20% glycitein) taken three times a day was found to be no more effective than placebo in reducing hot flashes.

No toxicity or recurrence of breast cancer was reported during the 9-week study period.

MANAGEMENT: Until more information is available, patients treated with toremifene should consider avoiding the consumption of grapefruit juice and soy-containing products.

Patients should be advised to contact their physician if they experience vaginal bleeding or potential signs of blood clots such as chest pain, shortness of breath, sudden loss of vision, and pain, redness or swelling in an extremity.

Patients should seek immediate medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, palpitations, or syncope.

Volume of Distribution

  • 580 L

Elimination Route

Well absorbed

Half Life

5 days

Clearance

  • 5 L/h

Elimination Route

Toremifenum is extensively metabolized, principally by CYP3A4 to N-demethyltoremifene, which is also antiestrogenic but with weak in vivo antitumor potency.

Innovators Monograph

You find simplified version here Toremifenum

http://classyfire.wishartlab.com/tax_nodes/C0000000
http://classyfire.wishartlab.com/tax_nodes/C0000261
http://classyfire.wishartlab.com/tax_nodes/C0000253
http://classyfire.wishartlab.com/tax_nodes/C0000253
http://classyfire.wishartlab.com/tax_nodes/C0000369
http://classyfire.wishartlab.com/tax_nodes/C0004742
http://classyfire.wishartlab.com/tax_nodes/C0002341
http://classyfire.wishartlab.com/tax_nodes/C0000128
http://classyfire.wishartlab.com/tax_nodes/C0002239
http://classyfire.wishartlab.com/tax_nodes/C0004557
http://classyfire.wishartlab.com/tax_nodes/C0001516
http://classyfire.wishartlab.com/tax_nodes/C0004150
http://classyfire.wishartlab.com/tax_nodes/C0001026
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9635
http://www.hmdb.ca/metabolites/HMDB0014679
http://www.genome.jp/dbget-bin/www_bget?cpd:C08166
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3005573
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506087
https://www.chemspider.com/Chemical-Structure.2275722.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=58492
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=38409
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=9635
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1655
https://zinc.docking.org/substances/ZINC000012404516
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000793
http://www.pharmgkb.org/drug/PA451731
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/T0R
http://www.rxlist.com/cgi/generic2/toremifene.htm
https://www.drugs.com/cdi/toremifene.html
https://en.wikipedia.org/wiki/Toremifene
*** Taking medicines without doctor's advice can cause long-term problems.
Share